Browsing by Author "Billo, N"

Now showing 1 - 4 of 4
  • No Thumbnail Available
    Item
    Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)
    Bousquet, J; Pham-Thi, N; Bedbrook, A; Agache, I; Annesi-Maesano, I; Ansotegui, I; Anto, JM; Bachert, C; Benveniste, S; Bewick, M; Billo, N; Bosnic-Anticevich, S; Bosse, I; Brusselle, G; Calderon, MA; Canonica, GW; Caraballo, L; Cardona, V; Carriazo, AM; Cash, E; Cecchi, L; Chu, DK; Colgan, E; Costa, E; Cruz, AA; Czarlewski, W; Durham, S; Ebisawa, M; Erhola, M; Fauquert, JL; Fokkens, WJ; Fonseca, JA; Guldemond, N; Iinuma, T; Illario, M; Klimek, L; Kuna, P; Kvedariene, V; Larenas-Linneman, D; Laune, D; Le, LTT; Lourenço, O; Malva, JO; Marien, G; Menditto, E; Mullol, J; Münter, L; Okamoto, Y; Onorato, GL; Papadopoulos, NG; Perala, M; Pfaar, O; Phillips, A; Phillips, J; Pinnock, H; Portejoie, F; Quinones-Delgado, P; Rolland, C; Rodts, U; Samolinski, B; Sanchez-Borges, M; Schünemann, HJ; Shamji, M; Somekh, D; Togias, A; Toppila-Salmi, S; Tsiligianni, I; Usmani, O; Walker, S; Wallace, D; Valiulis, A; Van der Kleij, R; Ventura, MT; Williams, S; Yorgancioglu, A; Zuberbier, T
  • No Thumbnail Available
    Item
    Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
    Bousquet, JJ; Schünemann, HJ; Togias, A; Erhola, M; Hellings, PW; Zuberbier, T; Agache, I; Ansotegui, IJ; Anto, JM; Bachert, C; Becker, S; Bedolla-Barajas, M; Bewick, M; Bosnic-Anticevich, S; Bosse, I; Boulet, LP; Bourrez, JM; Brusselle, G; Chavannes, N; Costa, E; Cruz, AA; Czarlewski, W; Fokkens, WJ; Fonseca, JA; Gaga, M; Haahtela, T; Illario, M; Klimek, L; Kuna, P; Kvedariene, V; Le, LTT; Larenas-Linnemann, D; Laune, D; Lourenço, OM; Menditto, E; Mullo, J; Okamoto, Y; Papadopoulos, N; Nhân, PT; Picard, R; Pinnock, H; Roche, N; Roller-Wirnsberger, RE; Rolland, C; Samolinski, B; Sheikh, A; Toppila-Salmi, S; Tsiligianni, I; Valiulis, A; Valovirta, E; Vasankari, T; Ventura, MT; Walker, S; Williams, S; Akdis, CA; Annesi-Maesano, I; Arnavielhe, S; Basagana, X; Bateman, E; Bedbrook, A; Bennoor, KS; Benveniste, S; Bergmann, KC; Bia, S; Billo, N; Bindslev-Jensen, C; Bjermer, L; Blain, H; Bonini, M; Bonniaud, P; Bouchard, J; Briedis, V; Brightling, CE; Brozek, J; Buhl, R; Buonaiuto, R; Canonica, GW; Cardona, V; Carriazo, AM; Carr, W; Cartier, C; Casale, T; Cecchi, L; Sarabia, AMC; Chkhartishvili, E; Chu, DK; Cingi, C; Colgan, E; de Sousa, JC; Courbis, AL; Custovic, A; Cvetkosvki, B; D'Amato, G; da Silva, J; Dantas, C; Dokic, D; Dauvilliers, Y; Dedeu, A; De Feo, G; Devillier, P; Di Capua, S; Dykewickz, M; Dubakiene, R; Ebisawa, M; El-Gamal, Y; Eller, E; Emuzyte, R; Farrell, J; Fink-Wagner, A; Fiocchi, A; Fontaine, JF; Gemicioglu, B; Schmid-Grendelmeir, P; Gamkrelidze, A; Garcia-Aymerich, J; Gomez, M; Diaz, SG; Gotua, M; Guldemond, NA; Guzmán, MA; Hajjam, J; Hourihane, JO; Humbert, M; Iaccarino, G; Ierodiakonou, D; Ivancevich, JC; Joos, G; Jung, KS; Jutel, M; Kaidashev, I; Kalayci, O; Kardas, P; Keil, T; Khaitov, M; Khaltaev, N; Kleine-Tebbe, J; Kowalski, ML; Kritikos, V; Kull, I; Leonardini, L; Lieberman, P; Lipworth, B; Carlsen, KCL; Loureiro, CC; Louis, R; Mair, A; Marien, G; Mahboub, B; Malva, J; Manning, P; Keenoy, ED; Marshall, GD; Masjedi, MR; Maspero, JF; Mathieu-Dupas, E; Matricardi, PM; Melén, E; Melo-Gomes, E; Meltzer, EO; Mercier, J; Miculinic, N; Mihaltan, F; Milenkovic, B; Moda, G; Mogica-Martinezl, MD; Mohammad, Y; Montefort, S; Monti, R; Morais-Almeida, M; Mösges, R; Münter, L; Muraro, A; Murray, R; Naclerio, R; Napoli, L; Namazova-Baranova, L; Neffen, H; Nekam, K; Neou, A; Novellino, E; Nyembue, D; O'Hehir, R; Ohta, K; Okubo, K; Onorato, G; Ouedraogo, S; Pali-Schöll, I; Palkonen, S; Panzner, P; Park, HS; Pépin, JL; Pereira, AM; Pfaar, O; Paulino, E; Phillips, J; Plavec, D; Popov, TA; Portejoie, F; Price, D; Prokopakis, EP; Pugin, B; Raciborski, F; Rajabian-Söderlund, R; Reitsma, S; Rodo, X; Romano, A; Rosario, N; Rottem, M; Ryan, D; Salimäki, J; Sanchez-Borges, MM; Sisul, JC; Solé, D; Somekh, D; Sooronbaev, T; Sova, M; Spranger, O; Stellato, C; Stelmach, R; Ulrik, CS; Thibaudon, M; To, T; Todo-Bom, A; Tomazic, PV; Valero, AA; Valenta, R; Valentin-Rostan, M; van der Kleij, R; Vandenplas, O; Vezzani, G; Viart, F; Vieg, G; Wallace, D; Wagenmann, M; Wang, DY; Waserman, S; Wickman, M; Williams, DM; Wong, G; Wroczynski, P; Yiallouros, PK; Yorgancioglu, A; Yusuf, OM; Zar, HJ; Zeng, S; Zernotti, M; Zhang, L; Zhong, NS; Zidarn, M
    Background In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted patient activation, (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Sante as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
  • No Thumbnail Available
    Item
    Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014
    Bissell, K; Ellwood, P; Ellwood, E; Chiang, CY; Marks, GB; El Sony, A; Asher, I; Billo, N; Perrin, C; Asher, I; Billo, NE; Bissell, K; Chiang, CY; El Sony, A; Ellwood, P; García-Marcos, L; Mallol, J; Marks, GB; Pearce, N; Strachan, D; Priftanji, A; Boukari, R; Taright, S; Gómez, M; Baghdasaryan, A; Burgess, S; Marks, GB; Mattes, J; Tai, A; Riedler, J; Shpakou, A; Weyler, J; Lawin, H; de Abruzzese, JA; Domuz, S; Brandao, HV; Camargos, PAM; Fischer, GB; Menezes, AM; Neto, ACP; Rosário, N; Solé, D; Mustakov, TB; Birba, E; Ngahane, BHM; Tse, SM; Standring, P; Aguirre, V; Gil, MAC; Chen, YZ; Kan, X; Garcia, E; Niederbacher, J; Obel, BK; Soto-Quirós, ME; Banac, S; Yiallouros, P; Lochte, L; Barba, S; Bustos, C; El Falaki, M; Colorado, MF; Weihe, P; Lal, VA; Mäkelä, M; Annesi-Maesano, I; Raherison, C; Annesi-Maesano, I; Gotua, M; von Mutius, E; Addo-Yobo, EO; Akpinar-Elci, M; Lai, CKW; Novák, Z; Kabra, SK; Ilangho, RP; Pherwani, AV; Sharma, SK; Sukumaran, TU; Dalimunthe, W; Karimi, M; Masjedi, MR; Manning, P; Shohat, T; Forastiere, F; La Grutta, S; Petronio, MG; Piffer, S; Kahwa, E; Odajima, H; Abu-Ekteish, F; Amukoye, EI; Esamai, FO; Hong, SJ; Neziri-Ahmetaj, L; Momen, JA; Akkhavong, K; Svabe, V; Vlaski, E; Mortimer, K; Daud, M; Montefort, S; Navarro, BED; Gonzalez, CAJ; Merida-Palacio, JV; Paramo-Arroyo, RF; Munkhbayarlakh, S; Brunekreef, B; Annesi-Maesano, I; Asher, I; Currie, S; Douwes, J; Graham, D; Hancox, R; Moyes, C; Pattemore, P; Vis, K; Cordero, RMZ; Ayuk, A; Falade, AG; Garba, IB; Hammangabdo, A; Onyia, N; Pulu, M; Nystad, W; Al-Rawas, O; Yusuf, MO; Watson, BM; El Sharif, N; Cukier, G; Chiarella, P; Pagcatipunan, R; Brêborowicz, A; Lis, G; Morais-Almeida, M; Annesi-Maesano, I; Deleanu, D; Kamaltynova, E; Kondiurina, EG; Esera-Tulifau, L; Al-Ghamdi; Memish, ZA; Nahhas, MA; Yousef, A; Toure, NO; Visnjevac, D; Zivkovic, Z; Deen, GF; Goh, DYT; Masekala, R; Zar, HJ; Carvajal-Uruena, I; Garcia-Marcos, L; Diaz, CG; Murua, JK; Luna-Paredes, C; Morales-Suarez-Varela, M; Praena-Crespo, M; Kudagammana, ST; El Sony, A; Mohammad, Y; Guo, YL; Huang, JL; Lao-Araya, M; Teeratakulpisarn, J; Vichyanond, P; Anderson, S; Tidjani, O; Iosefa, T; Aho, G; Dookeeram, D; Hamzaoui, A; Yorgancioglu, A; Ituaso-Conway, N; Worodria, W; Fedortsiv, O; Mahboub, B; Mansur, AH; Kumar, H; Valentin-Rostan, M; Harrison, G; Fiocchi, A; Le, LTT; Wa Somwe, S; Manangazira, P
    Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013-2020 sets an 80% target for essential NCD medicines' availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013-2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system's capacity to address NCDs.
  • No Thumbnail Available
    Item
    Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases
    Bousquet, J; Nhân, PT; Bedbrook, A; Agache, I; Annesi-Maesano, I; Ansotegui, I; Anto, JM; Bachert, C; Benveniste, S; Bewick, M; Billo, N; Bosnic-Anticevich, S; Bosse, I; Brusselle, G; Calderon, MA; Canonica, GW; Caraballo, L; Cardona, V; Carriazo, AM; Cash, E; Cecchi, L; Chu, DK; Colgan, E; Costa, E; Cruz, AA; Czarlewski, W; Durham, S; Ebisawa, M; Erhola, M; Fauquert, JL; Fokkens, WJ; Fonseca, JA; Guldemond, N; Iinuma, T; Illario, M; Klimek, L; Kuna, P; Kvedariene, V; Larenas-Linneman, D; Laune, D; Le, LTT; Lourenço, O; Malva, JO; Marien, G; Menditto, E; Mullol, J; Münter, L; Okamoto, Y; Onorato, GL; Papadopoulos, NG; Perala, M; Pfaar, O; Phillips, A; Phillips, J; Pinnock, H; Portejoie, F; Quinones-Delgado, P; Rolland, C; Rodts, U; Samolinski, B; Sanchez-Borges, M; Schünemann, HJ; Shamji, M; Somekh, D; Togias, A; Toppila-Salmi, S; Tsiligianni, I; Usmani, O; Walker, S; Wallace, D; Valiulis, A; Van der Kleij, R; Ventura, MT; Williams, S; Yorgancioglu, A; Zuberbier, T